However, a recent study showed that DPP-4 inhibitors failed to decrease the progression of kidney damage despite reducing hyperglycaemia and renal DPP-4 activity in a murine model of DKD, suggesting that controlling hyperglycaemia alone is not sufficient for DKD prevention.146. This evidence concerns the gene DPP4 and Nephropathy.